Obestatin-mediated proliferation of human retinal pigment epithelial cells: Regulatory mechanisms

Journal of Cellular Physiology

Volumn 211, Issue 1, 2007, Pages 1-9

  Camiña, Jesus P ^a,b   Campos, Jacobo F ^a,b   Caminos, J Eduardo ^b   Dieguez, Carlos ^b   Casanueva, Felipe F ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; CALPHOSTIN C; GHRELIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; OBESTATIN; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE C MU; PROTEIN KINASE C THETA; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CELL CULTURE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; ENZYME ACTIVATION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, BIOLOGICAL; PEPTIDE HORMONES; PERTUSSIS TOXIN; PHOSPHORYLATION; PIGMENT EPITHELIUM OF EYE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS PP60(C-SRC); RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 33847642830     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20925     Document Type: Article

References (58)

1. Aksunger A, Or M, Okur H, Hasanreisogl B, Akbatur H. 1997. Role of interleukin 8 in the pathogenesis of proliferative vitreoretinopathy. Ophthalmologica 211:223-225.
2. Andrews A, Balciunaite E, Leong FL, Tallquist M, Soriano P, Refojo M, Kazlauskas A. 1999. Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 40:2683-2689.
3. Armstrong D, Augustin AJ, Spengler R, Al-Jada A, Nickola T, Grus F, Koch F. 1998. Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. Ophthalmologica 212:410-414.
4. Baudouin C, Fredj-Reygrobellet D, Brignole F, Negre F, Lapalus P, Gastaud P. 1993. Growth factors in vitreous and subretinal fluid cells from patients with proliferative vitreoretinopathy. Ophthalmic Res 25:52-59.
5. Bochaton-Piallat ML, Kapetanios AD, Donati G, Redard M, Gabbiani G, Pournaras CJ. 2000. TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. Invest Ophthalmol Vis Sci 41:2336-2342.
6. Briggs MC, Grierson I, Hiscott P, Hunt JA. 2000. Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. Invest Ophthalmol Vis Sci 41:3085-3094.
7. Brown MT, Cooper JA. 1996. Regulation, substrates and functions of src. Biochim Biophys Acta 1287:121-149.
8. Campochiaro PA, Hackett SF, Vinores SA, Freund J, Csaky C, LaRochelle W, Henderer J, Johnson M, Rodriguez IR, Friedman Z, Derevjanik N, Droner J. 1994. Platelet-derived growth factor is an autocrine growth stimulator in retinal pigmented epithelial cells. J Cell Sci 107:2459-2469.
9. Carpenter CL, Cantley LC. 1996. Phosphoinositide kinases. Curr Opi Cell Biol 8:153-158.
10. Cassidy L. Barry P, Shaw C, Duffy J, Kennedy S. 1998. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br J Ophthalmol 82:181-185.
11. Chen C, Sytkowski AJ. 2001. Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 276:38518-38526.
12. Diaz-Rodriguez E, Pineiro A, Casanueva FF, Camina JP. 2005. The bovine vitreous-derived lipid factor (bVLF) is a powerful inhibitor of retinal pigmented epithelial (hRPE) cell proliferation. FEBS Lett 579:4020-4030.
13. Dodge-Kafka KL, Kapiloff MS. 2006. The mAKAP signaling complex: Integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol 85:593-602.
14. El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe PJ. 1999. Detection of cytokine mRNA production in infiltrating cells in proliferative vitreoretinopathy using reverse transcription polymerase chain reaction. Br J Ophthalmol 83:1296-1299.
15. El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe PJ. 2001. Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol 85:461-470.
16. Einer SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM. 1995. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy. Curr Eye Res 14:1045-1053.
17. Ettinger SL, Lauener RW, Duronio V. 1996. Protein kinase C delta specifically associates with phosphatidylinositol 3-kinase following cytokine stimulation. J Biol Chem 271:14514-14518.
18. Gao Y, Tang S, Zhou S, Ware JA. 2001. The thromboxane A2 receptor activates mitogen-activated protein kinase via protein kinase C-dependent Gi coupling and Src-dependent phosphorylation of the epidermal growth factor receptor. J Pharmacol Exp Ther 296:426-433.
19. Gariano RF, Gardner TW. 2005. Retinal angiogenesis in development and disease. Nature 438:960-966.
20. Graness A, Adomeit A, Heinze R, Wetzker R, Liebmann C. 1998. A novel mitogenic signaling pathway of bradykinin in the human colon carcinoma cell line SW-480 involves sequential activation of a Gq/11 protein, phosphatidylinositol 3-kinase beta, and protein kinase Cepsilon. J Biol Chem 273:32016-32022.
21. Gualillo O, Lago F, Casanueva FF, Dieguez C. 2006. One ancestor, several peptides Post-translational modifications of preproghrelin generate several peptides with antithetical effects. Mol Cell Endocrinol 256:1-8.
22. Gutkind JS. 2000. Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors. Sci STKE 2000:REI.
23. Hawes BE, Luttrell LM, van Biesen T, Lefkowitz RJ. 1996. Phosphatidylinositol 3-kinase is an early intermediate in the G beta gamma-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 271:12133-12136.
24. Heidenkummer HP, Kampik A. 1991. Immunohistochemical localization of epidermal growth factor receptor in a human epiretinal membrane. Graefes Arch Clin Exp Ophthalmol 229:492-496.
25. Hiscott P, Sheridan C, Magee RM, Grierson I. 1999. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 18:167-190.
26. Holst B, Holliday ND, Bach A, Elling CE, Cox HM, Schwartz TW. 2004. Common structural basis for constitutive activity of the ghrelin receptor family. J Biol Chem 279:53806-53817.
27. Holst B, Egerod KL, Schild E, Vickers SP, Cheetham S, Gerlach LO, Storjohann L, Stidsen CE, Jones R, Beck-Sickinger AG, Schwartz TW. 2006. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology (In press).
28. Hueber A, Wiedemann P, Esser P, Heimann K. 1997. Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR). Int Ophthalmol 20:345-350.
29. Kauffmann DJ, van Meurs JC, Mertens DA, Peperkamp E, Master C, Gerritsen ME. 1994. Cytokines in vitreous humor: Interleukin-6 is elevated in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35:900-906.
30. Klingmuller U, Wu H, Hsiao JG, Toker A, Duckworth BC, Cantley LC, Lodish HF. 1997. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 94:3016-3021.
31. Korte GE, Burns MS, Bellhorn RW. 1989. Epithelium-capillary interactions in the eye: The retinal pigment epithelium and the choriocapillaris. lnt Rev Cytol 114:221-248.
32. Kutty RK, Kutty G, Hooks JJ, Wiggert B, Nagineni CN. 1995. Transforming growth factor-beta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem Biophys Res Commun 215:386-393.
33. Leschey KH, Hackett SF, Singer JH, Campochiaro PA. 1990. Growth factor responsiveness of human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 31:839-846.
34. Limb GA, Little BC, Meager A, Ogilvie JA, Wolstencroft RA, Franks WA, Chignell AH, Dumonde DC. 1991. Cytokines in proliferative vitreoretinopathy. Eye 5:686-693.
35. Limb GA, Alam A, Earley O, Green W, Chignell AH, Dumonde DC. 1994a. Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy. Curr Eye Res 13:791-798.
36. Limb GA, Earley O, Jones SE, LeRoy F, Chignell AH, Dumonde DC. 1994b. Expression of mRNA coding for TNF alpha, IL-1 beta and IL-6 by cells infiltrating retinal membranes. Graefes Arch Clin Exp Ophthalmol 232:646-651.
37. Luttrell DK, Luttrell LM. 2004. Not so strange bedfellows: G-protein-coupled receptors and Src family kinases. Oncogene 23:7969-7978.
38. Lutty G, Grunwald J, Majji AB, Uyama M, Yoneya S. 1999. Changes in choriocapillaris and retinal pigment ephitelium in age related macular degeneration. Mol Vis 5:35.
39. Ma YC, Huang J, Ali S, Lowry W, Huang XY. 2000. Src tyrosine kinase is a novel direct effector of G proteins. Cell 102:635-646.
40. Malecaze F, Mathis A, Arne JL, Raulais D, Courtoi Y, Hicks D. 1991. Localization of acidic fibroblast growth factor in proliferative vitreoretinopathy membranes. Curr Eye Res 10:719-729.
41. Marmor MF. l998. The retinal pigment ephithelium. In: Marmor MF, Wolfensberger TJ, editors. Retinal Pigment Epithelium: Function and disease. New York; Oxford Press. 3-12.
42. Marras E, Concari P, Cortelleizi L, Dondi D, De Eguileor M, Perletti G. 2001. Involvement of PI3K in PKCepsilon-mediated oncogenic signal in rat colonic epithelial cells. Int J Oncol 19:395-399.
43. McKee KK, Tan CP, Palyha OC, Liu J, Feighner SD, Hreniuk DL, Smith RG, Howard AD, Van der Ploeg LH. 1997. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 46:426-434.
44. Mitamura Y, Takeuchi S, Matsuda A, Tagawa Y, Mizue Y, Nishihira J. 2000. Hepatocyte growth factor levels in the vitreous of patients with proliferative vitreoretinopathy. Am J Ophthalmol 129:678-680.
45. Moriya S, Kazlauskas A, Akimoto K, Hirai S, Mizuno K. Takenawa T, Fukui Y, Watanabe Y, Ozaki S, Ohno S. 1996. Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 93:151-155.
46. Nagasaki H, Shinagawa K, Mochizuki M. 1998. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 17:77-98.
47. Nagineni CN, Samuel W, Nagineni S, Pardhasaradhi K, Wiggert B, Detrick B, Hooks JJ. 2003. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: Involvement of mitogen-activated protein kinases. J Cell Physiol 197:453-462.
48. Nogueiras R, Tschop M. 2005. Biomedicine. Separation of conjoined hormones yields appetite rivals. Science 310:985-986.
49. Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I. 2003. Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Biochem Biophys Res Commun 303:962-967.
50. Parker PJ, Murray-Rust J. 2004. PKC at a glance. J Cell Sci 117:131-132.
51. Robbins SG, Mixon RN, Wilson DJ, Hart CE, RobertsonJE, Westra I, Planck SR, Rosenbaum JT. 1994. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. Invest Ophthalmol Vis Sci 35:3649-3663.
52. Song C, Vondriska TM, Wang GW, Klein JB, Cao X, Zhang J, Kang YJ, D'Souza S, Ping P. 2002. Molecular conformation dictates signaling module formation: Example of PKCepsilon and 5rc tyrosine kinase. Am J Physiol Heart Circ Physiol 282:H1166-H1171.
53. Tapinos N, Rambukkana A. 2005. Insights into regulation of human Schwann cell proliferation by Erk1/2 via a MEK-independent and p56Lck-dependent pathway from leprosy bacilli. Proc Natl Acad Sci USA 102:9188-9193.
54. Toker A, Meyer M, Reddy KK, Falck JR, Aneja R, Aneja S, Parra A, Burns DJ, Ballas LM, Cantley LC. 1994. Activation of protein kinase C family members by the novel polyphosphoinositides Ptdlns-3,4-P2 and Ptdlns-3,4,5-P3. J Biol Chem 269:32358-32367.
55. Vanhaesebroeck B, Ali K, Bilancio A, Geering B, Foukas LC. 2005. Signalling by PI3K isoforms: Insights from gene-targeted mice. Trends Biochem Sci 30:194-204.
56. Wiedemann P. 1992. Growth factors in retinal diseases: Proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration. Surv Ophthalmol 36:373-384.
57. Yart A, Chap H, Raynal P. 2002. Phosphoinositide 3-kinases in lysophosphatidic acid signaling: Regulation and cross-talk with the Ras/mitogen-activated protein kinase pathway. Biochim Biophys Acta 158:107-111.
58. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, Klein C, Hsueh AJ. 2005. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310:996-999.